BioStock: Cereno Scientific adds new drug candidate to development pipeline
Cereno Scientific’s collaboration with the top-ranked University of Michigan bears fruit once again with the signing of a new agreement for the development of the preclinical drug candidate CS585 within cardiovascular diseases. The preclinical development will be done at the University under the supervision of Dr Michael Holinstat, and the new agreement also includes the successful transition to a phase I clinical programme.Read the full article at biostock.se: https://www.biostock.se/en/cereno-scientific-adds-new-drug-candidate-to-development-pipeline/ This is a press release from
Today, 28 April, is the World Day for Safety and Health at Work. Continuous talk about workplace safety and health is important because that way we’re constantly paying attention to it in everyday life and finding new ways to improve it. At Kiilto, for example, the number of safety findings has shown a significant impact on accident prevention.Active measures for wellbeing at work support business and are therefore a vital part of good management. At Kiilto wellbeing is built in cooperation with different operations. For example, human resources, superiors, occupational safety and health
